Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02106819 · ClinicalTrials.gov registry record
Emotional Communication Disorders in Cerebellar Disease
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 56
- Enrollment target
NCT02106819 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 56 participants.
The verdict
NCT02106819 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The cerebellum has been linked to cognitive and emotional functions and there is increasing evidence that damage to posterior portions of the cerebellum can result in frontal-executive, visuospatial, and verbal deficits, including dysprosodia, and affective changes including blunting of affect or disinhibited and inappropriate behavior. Based on preliminary clinical observations and tests performed in the investigator's clinic, disorders of emotional communication may also be associated with cerebellar dysfunction. Emotional communication includes the production and comprehension of facial and prosodic expressions and is critical to maintaining positive and supportive relationships. Deficits in emotional communication can have devastating effects on relationships and on quality of life for those affected. Although deficits in affect and prosody have been reported in association with posterior cerebellar disorders, there are currently no studies systematically investigating emotional communication in individuals with cerebellar dysfunction. It is known that the cerebellum has strong connections with the cerebral cortex, especially the frontal lobes, and that cortical damage from stroke or neurodegenerative disease can result in disorders of emotional communication. Impairments in the integrity of cerebellar-cerebral networks from cerebellar disease may produce similar deficits in emotional communication. The purpose of this study is to systematically investigate and describe deficits in emotional communication in a series of patients with cerebellar disease. Participants will be individuals diagnosed with posterior cerebellar degeneration or damage from a non-hemorrhagic infarction, and age-matched neurologically healthy controls. Assessment will include a battery of tests of neuropsychological function as well as tests of emotional communication. Comprehension of emotional facial and prosodic expressions will be assessed as well as production of emotional communicat
Interventions
- BEHAVIORAL Testing of emotional communication ability
- PROCEDURE magnetic resonance imaging (MRI) of the brain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02106819
The ClinicalTrials.gov registry entry for NCT02106819 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Testing of emotional communication ability is the first listed.
NCT02106819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02106819 about?
NCT02106819 is a clinical study titled "Emotional Communication Disorders in Cerebellar Disease". The cerebellum has been linked to cognitive and emotional functions and there is increasing evidence that damage to posterior portions of the cerebellum can result in frontal-executive, visuospatial, and verbal deficits, including dysprosodia, and affective changes including blunting of affect or di...
What is the current status of trial NCT02106819?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2014-04. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT02106819?
The interventions under investigation include: Testing of emotional communication ability (BEHAVIORAL), magnetic resonance imaging (MRI) of the brain (PROCEDURE).
Who is sponsoring clinical trial NCT02106819?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.